Milind Ganjawala MS, MBA U.S. FDA

Mr. Milind Ganjawala serves as the Director of the Division of Drug Quality 2 (DDQ2), Office of Manufacturing and Product Quality (OMPQ), Office of Compliance (OC), Center for Drug Evaluation and Research (CDER), FDA. He began his service with FDA in 2009. Prior to coming to FDA, he had more than 20 years of experience in quality management positions within world-class Pharmaceutical/Biotech companies. He received a BS, M.S. and MBA degrees.